# Sciegen Pharmaceuticals Inc - Inspection Records Source: https://www.keypedia.com/companies/sciegen-pharmaceuticals-inc/814ff2a4-e264-431f-bffa-9932abda619d > Inspection records and compliance data for Sciegen Pharmaceuticals Inc in Hauppauge, New York. Access full analysis and detailed observations. --- ## Details - Name: Sciegen Pharmaceuticals Inc - FEI Number: 3008298016 - City: Hauppauge - State: New York - Country Name: United States - Address Line 1: 89 Arkay Dr - Zip Code: 11788 - Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK ## Related Documents - [FDA Inspection 1297968 - Sciegen Pharmaceuticals Inc - 2025-12-19](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/d3faa575-0975-4a44-9f38-ff5d4d5c76a1) — source: FDA, date: December 19, 2025 - [FDA Inspection 1297968 - Sciegen Pharmaceuticals Inc - 2025-12-19](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/dbc62b1e-da3f-4e51-b99e-d9e5f6698380) — classification: No Action Indicated (NAI), source: FDA, date: December 19, 2025 - [FDA Inspection 1229682 - Sciegen Pharmaceuticals Inc - 2024-02-20](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/c0bb89dd-507e-46db-a766-fad3d39acd40) — classification: No Action Indicated (NAI), source: FDA, date: February 20, 2024 - [FDA Inspection 1204858 - Sciegen Pharmaceuticals Inc - 2023-04-21](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/78debf30-0ef4-42cc-be44-6bb8ef0669d0) — classification: Official Action Indicated (OAI), source: FDA, date: April 21, 2023 - [483 - Sciegen Pharmaceuticals Inc - 2023-04-17](https://www.keypedia.com/records/483/sciegen-pharmaceuticals-inc/e2f9042a-4ff1-46f0-bbb2-f2cb753419c1) — source: FDA, date: April 17, 2023 - [483 - Sciegen Pharmaceuticals Inc - 2022-09-02](https://www.keypedia.com/records/483/sciegen-pharmaceuticals-inc/500247d4-c1a2-41f6-9bee-15b0e37ef216) — source: FDA, date: September 2, 2022 - [FDA Inspection 1178870 - Sciegen Pharmaceuticals Inc - 2022-09-02](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/2cf09840-dbd9-4665-b3f8-2df1a91433da) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 2, 2022 - [483 - Sciegen Pharmaceuticals Inc - 2021-12-20](https://www.keypedia.com/records/483/sciegen-pharmaceuticals-inc/1634f312-1a9c-465b-9cc8-830b78799bbc) — source: FDA, date: December 20, 2021 - [FDA Inspection 1159297 - Sciegen Pharmaceuticals Inc - 2021-12-20](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/6531e5fc-0ab2-40b5-ae2a-c83d5ed9f6a0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 20, 2021 - [EIR - Sciegen Pharmaceuticals Inc - 2019-06-21](https://www.keypedia.com/records/eir/sciegen-pharmaceuticals-inc/4efb8eb0-db23-4e94-a8e6-55482a840592) — source: FDA, date: June 21, 2019 - [FDA Inspection 1093708 - Sciegen Pharmaceuticals Inc - 2019-06-21](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/6983c090-ecdf-4b54-a422-dce8d783eebd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 21, 2019 - [FDA Inspection 1052720 - Sciegen Pharmaceuticals Inc - 2018-04-20](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/a8d7e0f4-29f3-4f7b-b8bf-f8cf5f0314e1) — classification: No Action Indicated (NAI), source: FDA, date: April 20, 2018 - [EIR - Sciegen Pharmaceuticals Inc - 2018-03-16](https://www.keypedia.com/records/eir/sciegen-pharmaceuticals-inc/97b96d96-bcf3-4cd3-9989-1544618d657f) — source: FDA, date: March 16, 2018 - [FDA Inspection 1051153 - Sciegen Pharmaceuticals Inc - 2018-03-16](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/778bd4b5-2ed5-491c-aef0-8ce51043e54c) — classification: No Action Indicated (NAI), source: FDA, date: March 16, 2018 - [FDA Inspection 1047471 - Sciegen Pharmaceuticals Inc - 2018-03-14](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/2a1b157d-8466-4119-958b-ed67a7f76a83) — classification: No Action Indicated (NAI), source: FDA, date: March 14, 2018 - [483 - Sciegen Pharmaceuticals Inc - 2015-01-09](https://www.keypedia.com/records/483/sciegen-pharmaceuticals-inc/5e31791b-c59c-42d6-8153-31d0bd380825) — source: FDA, date: January 9, 2015 - [EIR - Sciegen Pharmaceuticals Inc - 2013-09-18](https://www.keypedia.com/records/eir/sciegen-pharmaceuticals-inc/0ac6c06b-b069-480d-8d76-c8ef14f435d7) — source: FDA, date: September 18, 2013 - [EIR - Sciegen Pharmaceuticals Inc - 2013-04-02](https://www.keypedia.com/records/eir/sciegen-pharmaceuticals-inc/5aec1fd7-2062-4d7f-9d73-8bb1608fcd87) — source: FDA, date: April 2, 2013 - [483 - Sciegen Pharmaceuticals Inc - 2011-09-16](https://www.keypedia.com/records/483/sciegen-pharmaceuticals-inc/1d284827-ee38-4511-b570-a5c012157fbc) — source: FDA, date: September 16, 2011 ## Related Companies - [Lifecore Biomedical LLC](https://www.keypedia.com/companies/lifecore-biomedical-llc/8ff9e05e-cb2b-42d1-971d-9736e5f0e73c) - [Oxalis Labs](https://www.keypedia.com/companies/oxalis-labs/bc19741c-c2c0-43bc-80ad-91eda4acf921) - [Encube Ethicals Pvt. Ltd.](https://www.keypedia.com/companies/encube-ethicals-pvt-ltd/2bba05cc-6e4f-4020-8f97-3e56020b33a2) - [Innogenix, LLC.](https://www.keypedia.com/companies/innogenix-llc/0b066751-6110-474e-8c0e-cfa7821c4360) - [Osmotica Pharmaceutical US LLC](https://www.keypedia.com/companies/osmotica-pharmaceutical-us-llc/5dae0d09-f070-4928-97f6-cfe7043ff133) - [Bora Pharmaceuticals Injectables Inc](https://www.keypedia.com/companies/bora-pharmaceuticals-injectables-inc/d6e15b21-41fb-4f18-9638-893d3f44fcd1) - [Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site)](https://www.keypedia.com/companies/qilu-pharmaceutical-co-ltd-high-tech-zone-site/94263442-b5c4-4df8-b563-30ae0b9a4206) - [Mission Pharmacal Company](https://www.keypedia.com/companies/mission-pharmacal-company/91da96fe-b7e4-449c-b2cc-53a57bd7f2b6) - [MSD International GmbH (Puerto Rico Branch) LLC](https://www.keypedia.com/companies/msd-international-gmbh-puerto-rico-branch-llc/98d0fc68-f819-4431-899c-0483c3329777) - [Pharmco Laboratories Inc.](https://www.keypedia.com/companies/pharmco-laboratories-inc/b34e3481-0ea5-433a-9e03-ce66b44df443) ## Related Officers - [GDUFA Supervisory Investigator](https://www.keypedia.com/people/paul-c-mouris/0da88ac4-d475-412f-8505-5a43dc8aea41) - [Neil J. Bonzagni](https://www.keypedia.com/people/neil-j-bonzagni/67201e71-0bc0-45b8-b5f5-4c24d80b9325) - [Biotechnology Specialist at FDA](https://www.keypedia.com/people/robert-c-horan/81b78f43-200d-4eaa-a586-fe2101759ffd) - [Jogy George](https://www.keypedia.com/people/jogy-george/00ef0915-66d2-4b34-9b74-d1e08caf2db3) - [Lata C. Mathew](https://www.keypedia.com/people/lata-c-mathew/0610a0ef-dcc5-43e7-ab74-2ac54d758beb)